Inflammation and Coronary Endothelial Function

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 111 participants.

Also called NCT02366091

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose other
Phase
Phase 2
Enrolled
  • 111 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02366091
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02366091. Randomized; triple masking; primary purpose other. Start 2015-01 (actual); primary completion 2020-08-01 (actual). Results posted on 2021-10-21.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Inflammation and Coronary Endothelial Function
Intervention (Drug)
Methotrexate
Intervention (Drug)
Colchicine
Intervention (Drug)
Placebo
Lead sponsor
Johns Hopkins University (class: other)
Collaborator
National Heart, Lung, and Blood Institute (NHLBI) (class: US National Institutes of Health)

Record details

Record id
cardio:ct-nct02366091
Content hash
3c6a3137c7804d3d25b6a6547d0d918e7c642c18a65e04db874704681f903794